Bluejay Diagnostics (BJDX) Assets (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Assets for 2 consecutive years, with $8.2 million as the latest value for Q3 2023.

  • Quarterly Assets fell 47.49% to $8.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Sep 2023, down 47.49% year-over-year, with the annual reading at $13.5 million for FY2022, N/A changed from the prior year.
  • Assets hit $8.2 million in Q3 2023 for Bluejay Diagnostics, down from $8.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $20.1 million in Q1 2022 to a low of $8.2 million in Q3 2023.